Description

CGL5 is a sterile peptide formulation containing cagrilintide at 5 mg per 10 mL vial, supplied as a pack of 10 vials. The product is intended for preclinical and in‑vitro research into glucagon‑like peptide/glucagon receptor family pharmacology, appetite‑regulation and energy‑homeostasis signalling, receptor pharmacology, and related cellular and molecular biology studies. Typical applications include receptor binding and functional assays, cell‑culture experiments, signalling‑pathway investigations, and assay development/validation.Physical/analytical details: exact sequence/identity confirmation, excipients, formulation vehicle, pH, preservative status (if any), sterility and endotoxin test results, potency/specific‑activity, and stability/expiry information are batch‑specific and provided on the Certificate of Analysis supplied with each lot.Storage and handling: store and handle as specified on the Certificate of Analysis (commonly refrigerated or frozen per batch instructions). Reconstitute and use only under appropriate laboratory aseptic conditions.

Product Usage: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. Use is restricted to in‑vitro testing and laboratory experimentation by qualified personnel. Bodily introduction into humans or animals is strictly forbidden. This product is not a drug, food, or cosmetic and must not be misbranded, misused, or administered.